Arterial PET Scanner

Unlocking the Full Potential of Quantitative PET

Currently in Development

For Investigational Purposes Only

A compact, non-invasive PET Scanner that circles the wrist or ankle; it determines the arterial input function essential for quantitative PET. The Arterial PET Scanner is in continuing development.

The SynchroPET Arterial PET Scanner is designed to:

  • In the future provide improved diagnoses in clinical treatment; it is currently being used for investigative purposes in therapeutic validation.  The results for the input function should compare favorably to the Standard Uptake Value (SUV model)
  • Accelerate the process of drug discovery that utilizes PET imaging
  • Accelerate the development of new PET Radiopharmaceuticals
  • Eliminate the need for an arterial catheter in PET Studies

The Arterial PET Scanner is designed to determine the input function essential for truly quantitative PET.  Conventionally, the Standard Uptake Value (SUV)—a semi quantitative analysis–is used to determine the amount of radio tracer observed by a Positron Emission Tomographic scan (PET Scan) and is commonly used in flourodeoxygluse (FDG) imaging (often with FDG 18).  Certainly, this quantification is extremely valuable (ref: http://jnm.snmjournals.org/content/45/9/1431.full).

The Arterial PET Scanner is non-invasive and eliminates the need for an arterial catheter.  The goal of the  Arterial PET Scanner is to provide improved diagnosis in  clinical treatment; and is currently being used for investigative purposes in therapeutic validation.

The results of the  Arterial PET Scanner should deliver data “at least as good as” or surpassing that of the SUV model.

The development of PET radiopharmaceuticals and drug discovery that incorporates PET imaging should be greatly advanced with the utilization of the Arterial Scanner.